« Back
Home /
Clazakizumab Biosimilar(Anti-IL-6 / IFNb2 Reference Antibody)

Clazakizumab Biosimilar(Anti-IL-6 / IFNb2 Reference Antibody)

Item no.	DCC-A271-100mg
Manufacturer	DCChemicals
CASRN	1236278-28-6
Amount	100 mg
Specific against	other
Available
Manufacturer - Applications	Clazakizumab is a monoclonal antibody with high affinity and specificity for the IL-6 (interleukin-6) cytokine. Clazakizumab may be helpful in inhibiting the cytokine response to SARS-CoV-2 in COVID-19. Clazakizumab can be used for the research of psoriatic arthritis (PsA) and renal antibody-mediated rejection.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 100 mg

available

Delivery expected until 6/19/2025

Express Delivery: Save 3 days

Compare

Add to wishlist

Recommend by mail